In the UK Biobank, an analysis of approximately 4,700 patients revealed that, even after adjusting for apolipoprotein E (APOE) and AD genetic risk scores, the increased risk for black individuals remains significant. The gene discussed is APOE; the disease is Alzheimer disease.